October 27, 2009 at 18:07 PM EDT
Hospira Beats Views, Boosts Drug Group
Generic-drug makers powered into the top 20 industry groups this week, up from a No. 161 ranking just eight weeks ago. A top draw in that advance, Hospira (HSP), topped analysts' earnings estimates by a wide margin Tuesday. Hospira was a 2004 spinoff from diversified drug giant Abbott Labs (ABT). It has surged 122% from its low in March and is just below its February 2006 all-time high. More than half of Hospira's revenue comes from injectable
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here